Fasenra is a prescription medicine used to treat the symptoms of Severe Asthma. Fasenra may be used alone or with other medications.
Fasenra belongs to a class of drugs called Interleukin Inhibitors; Monoclonal Antibodies, and Anti-asthmatics.
Benralizumab is a humanized monoclonal antibody (IgG1/κ-class) selective for the interleukin-5 receptor alpha subunit (IL5Rα). Benralizumab is produced in Chinese hamster ovary cells by recombinant DNA technology. Benralizumab has a molecular weight of approximately 150 kDa.
The most common side effects include:
There are several programs patients can sign up for that will assist in treatment costs:
To learn more about this treatment, browse the resources below.
Contact us to chat with one of our helpful scheduling specialists!